Instituto de Investigación Sanitaria Aragón Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT04028258
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Instituto de Investigación Sanitaria Aragón | Rosa Tarrago